CONSTANCE BRIDGES: Open Payments
NPI 1487005567 · OAKLAND, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 15 payments from 11 companies in 2025. Trend: 2023 $226 · 2024 $165 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $56 |
| Abbott Laboratories | 2 | $43 |
| ABBVIE INC. | 2 | $30 |
| PFIZER INC. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Boston Scientific Corporation | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Wegovy, VRAYLAR, NURTEC ODT, TZIELD, WATCHMAN Access System, Ozempic, JARDIANCE.
Industry payments across IA — which companies pay providers there.
